Global Endometriosis Therapies Market Research Report 2019

Table of Contents

Executive Summary

1 Endometriosis Therapies Market Overview

• 1.1 Product Overview and Scope of Endometriosis Therapies
• 1.2 Endometriosis Therapies Segment by Type
  • 1.2.1 Global Endometriosis Therapies Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Hormonal Contraceptives
  • 1.2.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists
  • 1.2.4 Progestin Therapy
  • 1.2.5 Aromatase Inhibitors
• 1.3 Endometriosis Therapies Segment by Application
  • 1.3.1 Endometriosis Therapies Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Endometriosis Therapies Market by Region
  • 1.4.1 Global Endometriosis Therapies Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Endometriosis Therapies Market Size
  • 1.5.1 Global Endometriosis Therapies Revenue (2014-2025)
  • 1.5.2 Global Endometriosis Therapies Production (2014-2025)

2 Global Endometriosis Therapies Market Competition by Manufacturers

• 2.1 Global Endometriosis Therapies Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Endometriosis Therapies Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Endometriosis Therapies Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Endometriosis Therapies Production Sites, Area Served, Product Types
• 2.5 Endometriosis Therapies Market Competitive Situation and Trends
  • 2.5.1 Endometriosis Therapies Market Concentration Rate
  • 2.5.2 Endometriosis Therapies Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Endometriosis Therapies Production Market Share by Regions

• 3.1 Global Endometriosis Therapies Production Market Share by Regions
• 3.2 Global Endometriosis Therapies Revenue Market Share by Regions (2014-2019)
• 3.3 Global Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Endometriosis Therapies Production
  • 3.4.1 North America Endometriosis Therapies Production Growth Rate (2014-2019)
  • 3.4.2 North America Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Endometriosis Therapies Production
  • 3.5.1 Europe Endometriosis Therapies Production Growth Rate (2014-2019)
  • 3.5.2 Europe Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Endometriosis Therapies Production (2014-2019)
  • 3.6.1 China Endometriosis Therapies Production Growth Rate (2014-2019)
  • 3.6.2 China Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Endometriosis Therapies Production (2014-2019)
  • 3.7.1 Japan Endometriosis Therapies Production Growth Rate (2014-2019)
  • 3.7.2 Japan Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Endometriosis Therapies Consumption by Regions

• 4.1 Global Endometriosis Therapies Consumption by Regions
• 4.2 North America Endometriosis Therapies Consumption (2014-2019)
• 4.3 Europe Endometriosis Therapies Consumption (2014-2019)
• 4.4 China Endometriosis Therapies Consumption (2014-2019)
• 4.5 Japan Endometriosis Therapies Consumption (2014-2019)

5 Global Endometriosis Therapies Production, Revenue, Price Trend by Type

• 5.1 Global Endometriosis Therapies Production Market Share by Type (2014-2019)
• 5.2 Global Endometriosis Therapies Revenue Market Share by Type (2014-2019)
• 5.3 Global Endometriosis Therapies Price by Type (2014-2019)
• 5.4 Global Endometriosis Therapies Production Growth by Type (2014-2019)

6 Global Endometriosis Therapies Market Analysis by Applications

• 6.1 Global Endometriosis Therapies Consumption Market Share by Application (2014-2019)
• 6.2 Global Endometriosis Therapies Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Endometriosis Therapies Business

• 7.1 AbbVie
  • 7.1.1 AbbVie Endometriosis Therapies Production Sites and Area Served
  • 7.1.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.1.3 AbbVie Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Eli Lilly
  • 7.2.1 Eli Lilly Endometriosis Therapies Production Sites and Area Served
  • 7.2.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.2.3 Eli Lilly Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 AstraZeneca
  • 7.3.1 AstraZeneca Endometriosis Therapies Production Sites and Area Served
  • 7.3.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.3.3 AstraZeneca Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bayer
  • 7.4.1 Bayer Endometriosis Therapies Production Sites and Area Served
  • 7.4.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.4.3 Bayer Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Astellas Pharma
  • 7.5.1 Astellas Pharma Endometriosis Therapies Production Sites and Area Served
  • 7.5.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.5.3 Astellas Pharma Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Meditrina Pharmaceuticals
  • 7.6.1 Meditrina Pharmaceuticals Endometriosis Therapies Production Sites and Area Served
  • 7.6.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Pfizer
  • 7.7.1 Pfizer Endometriosis Therapies Production Sites and Area Served
  • 7.7.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.7.3 Pfizer Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Neurocrine Biosciences
  • 7.8.1 Neurocrine Biosciences Endometriosis Therapies Production Sites and Area Served
  • 7.8.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.8.3 Neurocrine Biosciences Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Takeda Pharmaceutical
  • 7.9.1 Takeda Pharmaceutical Endometriosis Therapies Production Sites and Area Served
  • 7.9.2 Endometriosis Therapies Product Introduction, Application and Specification
  • 7.9.3 Takeda Pharmaceutical Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served

8 Endometriosis Therapies Manufacturing Cost Analysis

• 8.1 Endometriosis Therapies Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Endometriosis Therapies
• 8.4 Endometriosis Therapies Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Endometriosis Therapies Distributors List
• 9.3 Endometriosis Therapies Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Endometriosis Therapies Market Forecast

• 11.1 Global Endometriosis Therapies Production, Revenue Forecast
  • 11.1.1 Global Endometriosis Therapies Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Endometriosis Therapies Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Endometriosis Therapies Price and Trend Forecast (2019-2025)
• 11.2 Global Endometriosis Therapies Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Endometriosis Therapies Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Endometriosis Therapies Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Endometriosis Therapies Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Endometriosis Therapies Production, Revenue Forecast (2019-2025)
• 11.3 Global Endometriosis Therapies Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Endometriosis Therapies Consumption Forecast (2019-2025)
  • 11.3.2 Europe Endometriosis Therapies Consumption Forecast (2019-2025)
  • 11.3.3 China Endometriosis Therapies Consumption Forecast (2019-2025)
  • 11.3.4 Japan Endometriosis Therapies Consumption Forecast (2019-2025)
• 11.4 Global Endometriosis Therapies Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Endometriosis Therapies Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List